Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of proteasomal turnover of a p97-dependent reporter substrate in human cells - Hit Optimization Round 3
Assay data:40 Active, 2 Activity ≤ 1 µM, 65 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition
Assay data:925 Active, 218117 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Confirmation biochemical high-throughput screening assay for inhibitors of the p97 ATPase
Assay data:333 Active, 759 Tested
Dose response biochemical high throughput screening assay for inhibitors of the p97 ATPase
Assay data:5 Active, 54 Tested
Luminescence counterscreen assay for p97 inhibitors: Dose response biochemical high throughput screening assay to identify inhibitors of the C522A mutant p97 ATPase.
Assay data:1 Active, 54 Tested
Luminescence dose response biochemical high throughput screening assay for inhibitors of the p97 ATPase: synthesized compounds.
Assay data:1 Active, 16 Tested
Luminescence counterscreen assay for p97 inhibitors: dose response biochemical high throughput screening assay to identify inhibitors of the C522A mutant p97 ATPase: synthesized compounds.
Assay data:16 Tested
SummaryPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Summary of probe development efforts to identify inhibitors of the p97 ATPase.
Assay data:1 Active, 1 Tested
siRNA Circadian Assay
Assay data:527 Active, 33364 Tested
SummaryPubMed CitationRelated BioAssays by Depositor
Late stage results from the probe development effort to identify inhibitors of the p97 ATPase.
Assay data:3 Active, 12 Tested
p97 ATPase dose response
Assay data:20 Active, 29 Tested
Inhibition of proteasomal turnover of a p97-dependent reporter substrate in human cells
Assay data:32 Active, 56 Tested
p97 ATPase dose response - Hit Optimization Round 2
Assay data:50 Active, 12 Activity ≤ 1 µM, 86 Tested
Inhibition of proteasomal turnover of a p97-dependent reporter substrate in human cells - Hit Optimization Round 2
Assay data:27 Active, 84 Tested
RNAi screen for vemurafenib enhancer genes in BRAFV600 melanoma - Primary Screen
Assay data:790 Active, 18119 Tested
Summary
p97 ATPase dose response - Hit Optimization Round 3
Assay data:45 Active, 24 Activity ≤ 1 µM, 65 Tested
Inhibition of p97-independent reporter turnover
Assay data:12 Active, 21 Tested
An siRNA screen for human genes that are involved in human papilloma virus (HPV) E2 transcriptional repression of the E6 and E7 oncogenes
Assay data:497 Active, 21019 Tested
SummaryPubMed Citation
Genome-wide high-content siRNA screens for regulators of Parkin translocation in selective mitophagy (Dharmacon Library)
Assay data:826 Active, 18119 Tested
Genome-wide high-content siRNA screens for regulators of Parkin translocation in selective mitophagy (Ambion Library)
Assay data:9227 Active, 64752 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on